#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Critical Role of the Virus-Encoded MicroRNA-155 Ortholog in the Induction of Marek's Disease Lymphomas


Notwithstanding the well-characterised roles of a number of oncogenes in neoplastic transformation, microRNAs (miRNAs) are increasingly implicated in several human cancers. Discovery of miRNAs in several oncogenic herpesviruses such as KSHV has further highlighted the potential of virus-encoded miRNAs to contribute to their oncogenic capabilities. Nevertheless, despite the identification of several possible cancer-related genes as their targets, the direct in vivo role of virus-encoded miRNAs in neoplastic diseases such as those induced by KSHV is difficult to demonstrate in the absence of suitable models. However, excellent natural disease models of rapid-onset Marek's disease (MD) lymphomas in chickens allow examination of the oncogenic potential of virus-encoded miRNAs. Using viruses modified by reverse genetics of the infectious BAC clone of the oncogenic RB-1B strain of MDV, we show that the deletion of the six-miRNA cluster 1 from the viral genome abolished the oncogenicity of the virus. This loss of oncogenicity appeared to be primarily due to the single miRNA within the cluster, miR-M4, the ortholog of cellular miR-155, since its deletion or a 2-nucleotide mutation within its seed region was sufficient to inhibit the induction of lymphomas. The definitive role of this miR-155 ortholog in oncogenicity was further confirmed by the rescue of oncogenic phenotype by revertant viruses that expressed either the miR-M4 or the cellular homolog gga-miR-155. This is the first demonstration of the direct in vivo role of a virus-encoded miRNA in inducing tumors in a natural infection model. Furthermore, the use of viruses deleted in miRNAs as effective vaccines against virulent MDV challenge, enables the prospects of generating genetically defined attenuated vaccines.


Vyšlo v časopise: Critical Role of the Virus-Encoded MicroRNA-155 Ortholog in the Induction of Marek's Disease Lymphomas. PLoS Pathog 7(2): e32767. doi:10.1371/journal.ppat.1001305
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001305

Souhrn

Notwithstanding the well-characterised roles of a number of oncogenes in neoplastic transformation, microRNAs (miRNAs) are increasingly implicated in several human cancers. Discovery of miRNAs in several oncogenic herpesviruses such as KSHV has further highlighted the potential of virus-encoded miRNAs to contribute to their oncogenic capabilities. Nevertheless, despite the identification of several possible cancer-related genes as their targets, the direct in vivo role of virus-encoded miRNAs in neoplastic diseases such as those induced by KSHV is difficult to demonstrate in the absence of suitable models. However, excellent natural disease models of rapid-onset Marek's disease (MD) lymphomas in chickens allow examination of the oncogenic potential of virus-encoded miRNAs. Using viruses modified by reverse genetics of the infectious BAC clone of the oncogenic RB-1B strain of MDV, we show that the deletion of the six-miRNA cluster 1 from the viral genome abolished the oncogenicity of the virus. This loss of oncogenicity appeared to be primarily due to the single miRNA within the cluster, miR-M4, the ortholog of cellular miR-155, since its deletion or a 2-nucleotide mutation within its seed region was sufficient to inhibit the induction of lymphomas. The definitive role of this miR-155 ortholog in oncogenicity was further confirmed by the rescue of oncogenic phenotype by revertant viruses that expressed either the miR-M4 or the cellular homolog gga-miR-155. This is the first demonstration of the direct in vivo role of a virus-encoded miRNA in inducing tumors in a natural infection model. Furthermore, the use of viruses deleted in miRNAs as effective vaccines against virulent MDV challenge, enables the prospects of generating genetically defined attenuated vaccines.


Zdroje

1. JavierRT

ButelJS

2008 The history of tumor virology. Cancer Res 68 7693 7706

2. CroceCM

2008 Oncogenes and cancer. N Engl J Med 358 502 511

3. CroceCM

2009 Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10 704 714

4. VenturaA

JacksT

2009 MicroRNAs and cancer: short RNAs go a long way. Cell 136 586 591

5. QinZ

KearneyP

PlaisanceK

ParsonsCH

2010 Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J Leukoc Biol 87 25 34

6. LeiX

BaiZ

YeF

XieJ

KimCG

2010 Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12 193 199

7. CullenBR

2009 Viral and cellular messenger RNA targets of viral microRNAs. Nature 457 421 425

8. SchatKA

NairV

2008 Marek's Disease.

SaifYM

FadlyAM

GlissonJR

McDougaldLR

NolanLK

Diseases of Poultry. 12 ed Iowa Blackwell Publishing 452 514

9. CalnekBW

1986 Marek's disease: a model for herpesvirus oncology. CRC Crit Rev Microbiol 12 293 320

10. LupianiB

LeeLF

CuiX

GimenoI

AndersonA

2004 Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc Natl Acad Sci U S A 101 11815 11820

11. BrownAC

BaigentSJ

SmithLP

ChattooJP

PetherbridgeLJ

2006 Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus. Proc Natl Acad Sci U S A 103 1687 1692

12. ZhaoY

KurianD

XuH

PetherbridgeL

SmithLP

2009 Interaction of Marek's disease virus oncoprotein Meq with heat-shock protein 70 in lymphoid tumour cells. J Gen Virol 90 2201 2208

13. LupianiB

LeeLF

CuiX

GimenoI

AndersonA

2004 Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc Natl Acad Sci U S A 101 11815 11820

14. SuchodolskiPF

IzumiyaY

LupianiB

AjithdossDK

GiladO

2009 Homodimerization of Marek's disease virus-encoded Meq protein is not sufficient for transformation of lymphocytes in chickens. J Virol 83 859 869

15. BrownAC

SmithLP

KgosanaL

BaigentSJ

NairV

2009 Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus. J Virol 83 11142 11151

16. YaoY

ZhaoY

XuH

SmithLP

LawrieCH

2008 MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs. J Virol 82 4007 4015

17. MorganR

AndersonA

BernbergE

KambojS

HuangE

2008 Sequence conservation and differential expression of Marek's disease virus microRNAs. J Virol 82 12213 12220

18. YaoY

ZhaoY

SmithLP

LawrieCH

SaundersNJ

2009 Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines. J Gen Virol 90 1551 1559

19. ZhaoY

YaoY

XuH

LambethL

SmithLP

2009 A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. J Virol 83 489 492

20. McClureLV

SullivanCS

2008 Kaposi's sarcoma herpes virus taps into a host microRNA regulatory network. Cell Host Microbe 3 1 3

21. GottweinE

MukherjeeN

SachseC

FrenzelC

MajorosWH

2007 A viral microRNA functions as an orthologue of cellular miR-155. Nature 450 1096 1099

22. MuylkensB

CoupeauD

DambrineG

TrappS

RasschaertD

2010 Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes. Arch Virol 155 1823 1837

23. TiliE

CroceCM

MichailleJJ

2009 miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol 28 264 284

24. FaraoniI

AntonettiFR

CardoneJ

BonmassarE

2009 miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792 497 505

25. RaiD

KimSW

McKellerMR

DahiaPL

AguiarRC

2010 Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci U S A 107 3111 3116

26. ValeriN

GaspariniP

FabbriM

BraconiC

VeroneseA

2010 Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A 107 6982 6987

27. TischerBK

von EinemJ

KauferB

OsterriederN

2006 Two-step Red-mediated recombination for versatile, high-efficiency markerless DNA manipulation in Escherichia coli. BioTechniques 40 1 6

28. LaliotiM

HeathJ

2001 A new method for generating point mutations in bacterial artificial chromosomes by homologous recombination in Escherichia coli. Nucleic Acids Res 29 E14

29. PetherbridgeL

BrownAC

BaigentSJ

HowesK

SaccoMA

2004 Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J Virol 78 13376 13380

30. ZhaoY

PetherbridgeL

SmithLP

BaigentS

NairV

2008 Self-excision of the BAC sequences from the recombinant Marek's disease virus genome increases replication and pathogenicity. Virol J 5 19

31. XuH

YaoY

ZhaoY

SmithLP

BaigentSJ

2008 Analysis of the expression profiles of Marek's disease virus-encoded microRNAs by real-time quantitative PCR. J Virol Methods 149 201 208

32. TamW

HughesSH

HaywardWS

BesmerP

2002 Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J Virol 76 4275 4286

33. PetherbridgeL

HowesK

BaigentSJ

SaccoMA

EvansS

2003 Replication-competent bacterial artificial chromosomes of Marek's disease virus: Novel tools for generation of molecularly defined herpesvirus vaccines. J Virol 8712 8718

34. GottweinE

CullenBR

2008 Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3 375 387

35. XuS

XueC

LiJ

BiY

CaoY

2011 Marek's disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway. J Virol 85 276 285

36. FaraoniI

AntonettiR

CardoneJ

BonmassarE

2009 miR-155 gene: A typical multifunctional microRNA. Biochim Biophys Acta 1792 497 505

37. LuF

WeidmerA

LiuCG

VoliniaS

CroceCM

2008 Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol 82 10436 10443

38. BolisettyMT

DyG

TamW

BeemonKL

2009 Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival. J Virol 83 12009 12017

39. SkalskyRL

SamolsMA

PlaisanceKB

BossIW

RivaA

2007 Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 81 12836 12845

40. LinnstaedtSD

GottweinE

SkalskyRL

LuftigMA

CullenBR

2010 Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol 84 11670 11678

41. LeeEC

YuD

Martinez de VelascoJ

TessarolloL

SwingDA

2001 A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73 56 65

42. WarmingS

CostantinoN

CourtDL

JenkinsNA

CopelandNG

2005 Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33 e36

43. PrentkiP

KrischHM

1984 In vitro insertional mutagenesis with a selectable DNA fragment. Gene 29 303 313

44. YuD

EllisHM

LeeEC

JenkinsNA

CopelandNG

2000 An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci U S A 97 5978 5983

45. ZhaoY

NairV

2010 Mutagenesis of the repeat regions of herpesviruses cloned as bacterial artificial chromosomes. Methods Mol Biol 634 53 74

46. Tahiri-AlaouiA

MatsudaD

XuH

PanagiotisP

BurmanL

2009 The 5′ leader of the mRNA encoding the marek's disease virus serotype 1 pp14 protein contains an intronic internal ribosome entry site with allosteric properties. J Virol 83 12769 12778

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 2
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#